GlassScriptPhysician profile
Tabitha Sue Wilson
NPI 1952764425
$400.37
in general payments reported to CMS, 2019-2025
16 companies · $130 in 2025
The $130 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.82 · 2020: $34.99 · 2021: $114 · 2022: $27.19 · 2023: $32.26 · 2024: $50.65 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $76.63 | 2021-2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Boston Scientific Corporation | $47.48 | 2024-2025 | Watchman Access System |
| Janssen Pharmaceuticals, INC | $32.26 | 2020-2025 | Invega Sustenna |
| Glaxosmithkline, LLC. | $26.58 | 2020-2021 | |
| Inspire Medical Systems, INC. | $26.40 | 2025 | Inspire |
| Biohaven Pharmaceuticals, INC. | $24.02 | 2021 | |
| Sanofi-Aventis U.S. LLC | $21.26 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.12 | 2024 | |
| Pfizer INC. | $18.98 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.94 | 2025 | Uzedy |
| Ultragenyx Pharmaceutical INC. | $17.88 | 2023 | |
| Exact Sciences Corporation | $17.04 | 2025 | Cologuard Collection Kit |
| Biogen, INC. | $14.83 | 2024 | Spinraza |
| Alkermes, INC. | $14.65 | 2025 | Aristada, Lybalvi |
| Novo Nordisk INC | $11.82 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.